M. Denton
Impact in
- Endocrinology top 1%
- Infections and bacterial resistance
- Vibrio bacteria research studies
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Cystic Fibrosis Research Advances 23
-
- Infections and bacterial resistance 10
- Vibrio bacteria research studies 3
- Co-authors
- D. Peckham (17 shared papers)V. Keer (5 shared papers)Mark H. Wilcox (6 shared papers)P. Parnell (5 shared papers)Peter M. Hawkey (5 shared papers)Kirstin Kerr (6 shared papers)S.P. Conway (3 shared papers)Stanley N. Deming (1 shared paper)
- Journals
- Journal of Cystic Fibrosis (14 papers)Journal of Antimicrobial Chemotherapy (6 papers)Journal of Hospital Infection (5 papers)Epidemiology and Infection (4 papers)European Journal of Clinical Microbiology & Infectious Diseases (3 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
M. Denton
45 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 110
- Endocrinology 349
- Molecular Medicine 322
- Applied Microbiology and Biotechnology 39
- Critical Care and Intensive Care Medicine 83
- Pulmonary and Respiratory Medicine 459
Countries citing papers authored by M. Denton
This map shows the geographic impact of M. Denton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Denton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Denton more than expected).
Fields of papers citing papers by M. Denton
This network shows the impact of papers produced by M. Denton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Denton. The network helps show where M. Denton may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Denton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 161 | |
| 2 | 2003 | 103 | |
| 3 | 2002 | 100 | |
| 4 | 1978 | 89 | |
| 5 | 1996 | 64 | |
| 6 | 2005 | 61 | |
| 7 | 2013 | 55 | |
| 8 | 2000 | 51 | |
| 9 | 2013 | 47 | |
| 10 | 2003 | 45 | |
| 11 | 2004 | 44 | |
| 12 | 2010 | 42 | |
| 13 | 1996 | 40 | |
| 14 | 1997 | 32 | |
| 15 | 2008 | 31 | |
| 16 | 1997 | 31 | |
| 17 | 2014 | 26 | |
| 18 | 2015 | 23 | |
| 19 | 2018 | 23 | |
| 20 | 2009 | 22 |
About M. Denton
M. Denton is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Molecular Biology, Molecular Medicine and Epidemiology, having authored 46 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (23 papers), Bacterial biofilms and quorum sensing (11 papers), Infections and bacterial resistance (10 papers), Antibiotic Resistance in Bacteria (8 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Vibrio bacteria research studies (3 papers), Pneumonia and Respiratory Infections (3 papers) and Nosocomial Infections in ICU (3 papers). The work is most often cited by research in Endocrinology (349 citations), Molecular Medicine (322 citations), Applied Microbiology and Biotechnology (39 citations), Critical Care and Intensive Care Medicine (83 citations) and Pulmonary and Respiratory Medicine (459 citations). M. Denton has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include D. Peckham, V. Keer, Mark H. Wilcox, P. Parnell, Peter M. Hawkey, Kirstin Kerr, S.P. Conway, Stanley N. Deming, K. Brownlee and P. Murphy. Their work appears in journals such as Journal of Cystic Fibrosis, Journal of Antimicrobial Chemotherapy, Journal of Hospital Infection, Epidemiology and Infection and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.